PROGRAM

ACTIVATOR

BLOCKER

INDICATIONS

COMMERCIAL RIGHTS

DISCOVERY

IND-ENABLING

PHASE 1

PHASE 2

AUTOLOGOUS

PROGRAM

ACTIVATOR

CEA

BLOCKER

HLA-A*02

INDICATIONS

Colorectal, Lung and Pancreatic

COMMERCIAL RIGHTS

Discovery

IND-Enabling

Phase1

Phase2


AUTOLOGOUS

PROGRAM

ACTIVATOR

MSLN

BLOCKER

HLA-A*02

INDICATIONS

Ovarian, Mesothelioma, Pancreatic, Colorectal, Lung

COMMERCIAL RIGHTS

Discovery

IND-Enabling

Phase1

Phase2


ALLOGENEIC

PROGRAM

UNDISCLOSED

ACTIVATOR

UNDISCLOSED

BLOCKER

UNDISCLOSED

INDICATIONS

UNDISCLOSED

COMMERCIAL RIGHTS

Discovery

IND-Enabling

Phase1

Phase2


ALLOGENEIC

PROGRAM

UNDISCLOSED

ACTIVATOR

UNDISCLOSED

BLOCKER

UNDISCLOSED

INDICATIONS

UNDISCLOSED

COMMERCIAL RIGHTS

Discovery

IND-Enabling

Phase1

Phase2


ALLOGENEIC

PROGRAM

UNDISCLOSED

ACTIVATOR

UNDISCLOSED

BLOCKER

UNDISCLOSED

INDICATIONS

UNDISCLOSED

COMMERCIAL RIGHTS

Discovery

IND-Enabling

Phase1

Phase2